Gabriella D. Guida
Bari, 70121, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Age-specific melanoma risk associated with melanocytic nevi: a pooled analysis from the M-SKIP project.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: July 31, 2025
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 10, 2025
Skin Photodamage and Melanomagenesis: A Comprehensive Review.
Journal: Cancers
Published: April 23, 2025
Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells.
Journal: International journal of molecular sciences
Published: December 18, 2024
Association of MC1R variants with melanoma risk and interaction with sun exposure: An M-SKIP project.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 07, 2024
Melanocortin-1 receptor (MC1R): a review for dermatologists.
Journal: Italian journal of dermatology and venereology
Published: February 20, 2024
Enhanced Delivery of 5-Aminolevulinic Acid by Lecithin Invasomes in 3D Melanoma Cancer Model.
Journal: Molecular pharmaceutics
Published: September 27, 2023
Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatment.
Journal: International journal of pharmaceutics
Published: September 01, 2023
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 16, 2023
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis.
Journal: NPJ microgravity
Published: May 31, 2022
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.
Journal: Molecular cancer
Published: October 04, 2021
Last Updated: 09/26/2026